ID   OV-2978
AC   CVCL_A1SM
SY   OV2978
DR   cancercelllines; CVCL_A1SM
DR   Wikidata; Q105510510
RX   PubMed=32784519;
CC   Doubling time: 3.8 +- 0.03 days (PubMed=32784519).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.920-2A>G (IVS8-2A>G); ClinVar=VCV000043595; Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=32784519).
CC   Omics: Deep exome analysis.
CC   Omics: Transcriptome analysis by microarray.
CC   Miscellaneous: STR profile from personal communication of Mes-Masson, Anne-Marie.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 12,13
ST   D21S11: 30,33.2
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9U73 ! TOV-2978G
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 8
//
RX   PubMed=32784519; DOI=10.3390/cancers12082222; PMCID=PMC7465288;
RA   Sauriol A., Simeone K., Portelance L., Meunier L.,
RA   Leclerc-Desaulniers K., de Ladurantaye M., Chergui M.,
RA   Kendall-Dupont J., Rahimi K., Carmona E., Provencher D.M.,
RA   Mes-Masson A.-M.;
RT   "Modeling the diversity of epithelial ovarian cancer through ten novel
RT   well characterized cell lines covering multiple subtypes of the
RT   disease.";
RL   Cancers (Basel) 12:2222.1-2222.26(2020).
//